Conversely, other retrospective studies have found a decreased risk of lung cancer in diabetic patients taking metformin vs those not on metformin, as well as improved overall survival in patients who received first-line chemotherapy for lung cancer concurrently with metformin vs insulin or other antidiabetic medications [13,14]. The gene discussed is INS; the disease is lung cancer.